Tetra Technologies, Inc. To Present At The H.C. Wainwright & Co 22nd Annual Global Investment Conference

Christel Deskins

THE WOODLANDS, Texas, Sept. 14, 2020 /PRNewswire/ — TETRA Technologies, Inc. (“TETRA” or the “Company”) (NYSE:TTI), announced that management will present at the H. C. Wainwright & Co., 22nd Annual Global Investment Conference on September 16, 2020. TETRA Technologies, Inc. logo. (PRNewsFoto/TETRA Technologies, Inc.) More Brady Murphy, President and Chief Executive […]

PolarityTE to Present at H.C. Wainwright 22nd Annual Global Investment Conference and Cantor Virtual Global Healthcare Conference

Christel Deskins

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and the Cantor Virtual Global Healthcare Conference on September 15, 2020. A live audio webcast of the H.C. […]

MaxCyte to Present at Upcoming 2020 H.C. Wainright & Co 22nd Annual Global Investment Virtual Conference

Christel Deskins

GAITHERSBURG, Md., Sept. 10, 2020 /PRNewswire/ — MaxCyte, a global cell-based therapies and life sciences company, today announced that CEO Doug Doerfler plans to present an overview of the company at the upcoming H.C. Wainright & Co 22nd Annual Global Investment Virtual Conference taking place September 14-16, 2020.  Details are as follows: […]

Remark Holdings to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference

Christel Deskins

LAS VEGAS, Sept. 10, 2020 /PRNewswire/ — Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence (“AI”) solutions and digital media properties, today announced that members of its management team are scheduled to participate in the H.C. Wainwright & Co. 22nd Annual Global Investment Conference on […]

ImmunoPrecise Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)

Christel Deskins

VICTORIA, BC, Sept. 9, 2020 /PRNewswire/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that it will be presenting at the H.C. Wainwright Annual Global Investment Conference being held virtually on September 14-16, 2020. Jennifer Bath, CEO of ImmunoPrecise, will provide an overview of the […]

Windtree to Present at H.C. Wainwright 22nd Annual Global Investment Conference

Christel Deskins

WARRINGTON, Pa., Sept. 8, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Frasier, president and chief executive officer, will present at the H.C. Wainwright 22nd Annual Global Investment Conference, […]